Renálida

Transforming the future of kidney care

 We understand that nephrology faces the challenge of providing effective solutions in the treatment of kidney diseases, particularly in their pre-dialysis stages. This challenge is reflected in the growing incidence of patients progressing to end-stage CKD, with the resulting need for dialysis.

Our commitment is to lead a meaningful change in this landscape through clinical research to improve the care and treatment of chronic kidney disease (CKD). Our active participation in national and international research projects allows us to be at the forefront of developing new strategies and treatments that benefit our patients and transform the future into KIDNEY HEALTH FOR ALL.

 

En Renálida, llevamos a cabo estudios clínicos innovadores que abarcan una amplia gama de diseños, desde descriptivos y analíticos hasta experimentales. Nos especializamos tanto en ensayos clínicos farmacológicos como en estudios no farmacológicos, generando conocimiento que contribuye a enlentecer la progresión de las enfermedades renales, a mejorar la calidad de vida de nuestros pacientes y a la mejora continúa de nuestros servicios.

Transforming the future of kidney care

We understand that nephrology faces the challenge of providing effective solutions in the treatment of kidney diseases, particularly in their pre-dialysis stages. This challenge is reflected in the growing incidence of patients progressing to end-stage CKD, with the resulting need for dialysis. Our commitment is to lead a meaningful change in this landscape through clinical research to improve the care and treatment of chronic kidney disease (CKD). Our active participation in national and international research projects allows us to be at the forefront of developing new strategies and treatments that benefit our patients and transform the future into KIDNEY HEALTH FOR ALL.

Commitment to Excellence in Clinical Research

Through Dr. Paula Marioli's participation as a member of the International Society of Nephrology Advancing Clinical Trials (ISN-ACT) Committee, we contribute to strengthening the global nephrology community's capacity to lead and participate in clinical trials. This collaboration allows us not only to enhance the quality of the clinical trials in which we participate, but also to share our experience and learn from leading figures in the field. In this way, we advance the optimal prevention and treatment of kidney disease and its complications.

ISN-ACT
ISN-ACT Comitee

Clinical Research at Renálida

At Renálida, clinical research is a fundamental pillar in advancing toward more effective and personalized therapies. Thanks to our model of early detection, longitudinal follow-up, and precise stratification of patients with kidney disease, we actively participate as a site in international multicenter clinical research protocols. This integration allows us to bring our patients closer to innovative, cutting-edge therapeutic alternatives, under strict ethical, regulatory, and Good Clinical Practice (GCP) standards.

Renálida - Active trials

BaxDuo-Arctic (D6972C00003)

A Phase 3 Study to Investigate the Efficacy and Safety of Baxdrostat in Combination with Dapagliflozin on the Progression of CKD in Participants with CKD and Hypertension

BaxDuo-Pacific (D6972C00002)

A Phase 3 Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination with Dapagliflozin in Participants with Chronic Kidney Disease and Hypertension

BaxDuo-Baltic (D6972C00006)

A Phase 2b Study to Evaluate the Effect of Dapagliflozin in Combination with Baxdrostat Compared with Baxdrostat on Albuminuria in Participants with Chronic Kidney Disease and Hypertension

ZENITH High Proteinuria (D4325C00010)

A Study to Investigate the Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared with Dapagliflozin in Participants with Chronic Kidney Disease and High Proteinuria

Novo Nordisk NN9541-7841:

A Research Study to Compare How Well Different Doses of the Medication NNC0519-0130 Can Reduce Kidney Damage in People Living with Chronic Kidney Disease